Nootropics, also known as smart drugs or cognitive enhancers, refer to substances that aim to enhance memory and cognitive function with a stimulant effect. These substances are utilized to boost brain performance and include caffeine, creatine, vitamins, and minerals. Nootropics are often used to increase memory, improve strength, or enhance other cognitive functions. It's important to note that while they may affect memory, thinking, or other mental functions, they do not treat diseases.
The main types of drugs categorized as nootropics include prescription nootropics and over-the-counter (OTC) nootropics. Prescription nootropics are often utilized to provide stimulant effects and may be prescribed to counteract symptoms associated with medical conditions such as attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, or narcolepsy. Nootropics are available in various forms, including capsules or tablets, powder, drinks, and others, and are distributed through multiple channels, both online and offline. They find application in memory enhancement, mood and depression treatment, attention and focus improvement, longevity and anti-aging efforts, sleep and recovery promotion, and anxiety treatment.
The nootropics market research report is one of a series of new reports that provides nootropics market statistics, including nootropics industry global market size, regional shares, competitors with a nootropics market share, detailed nootropics market segments, market trends and opportunities, and any further data you may need to thrive in the nootropics industry. This nootropics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nootropics market size has grown rapidly in recent years. It will grow from $4.6 billion in 2023 to $5.29 billion in 2024 at a compound annual growth rate (CAGR) of 15.0%. The growth observed in the historical period can be attributed to several factors, including an aging population, regulatory support for the industry, increased investment in research and development, the expansion of e-commerce, and the rise of esports.
The nootropics market size is expected to see rapid growth in the next few years. It will grow to $9.73 billion in 2028 at a compound annual growth rate (CAGR) of 16.5%.
The anticipated growth in the forecast period can be attributed to various factors, including the increasing stress and cognitive demands in modern lifestyles, globalization, rising disposable incomes allowing for discretionary spending on cognitive enhancement, a growing awareness of mental health, and the expansion of emerging markets. Major trends expected in this forecast period encompass the rise of natural and plant-based nootropics, the emergence of digital nootropics, the use of transcranial stimulation devices, a focus on sustainable and ethical sourcing of nootropic ingredients, and increased collaboration within the industry.
The anticipated growth in the nootropics market is driven by the increasing expenditure on health and wellness. Health and wellness, defined as an individual's method to achieve mental and physical well-being, play a crucial role in the growing demand for nootropics. As the expenditure on healthcare and wellness rises, so does the need for substances like nootropics that contribute to maintaining an individual's health. For example, in September 2021, the Centers for Medicare & Medicaid Services reported a 7.8% increase in prescription drug spending to $378.0 billion, reflecting a faster growth rate compared to the previous year. The escalating expenditure on healthcare and wellness is a key factor propelling the nootropics market.
The nootropics market is poised for growth due to the increasing prevalence of lifestyle diseases. Lifestyle diseases, driven by unhealthy lifestyle choices, lead to cognitive impairment, stress, and reduced energy levels. Nootropics are increasingly used to address these issues, enhancing cognitive function, managing stress, boosting energy, and supporting weight management. The World Health Organization reported 41 million deaths globally in September 2022, with 74% attributed to non-communicable diseases (NCDs). The rising prevalence of lifestyle diseases, such as obesity and diabetes, contributes to the growth of the nootropics market.
The global nootropics market is witnessing the popularity of vegan nootropics, with major companies introducing organic product innovations to meet consumer demands. For instance, BioAdaptives Inc. launched MindMemory, an advanced nootropic designed to enhance memory, mental focus, and concentration, appealing to consumers seeking natural plant and algae-based supplements. This trend reflects the industry's response to the growing demand for vegan-friendly nootropic options.
Major players in the nootropics market are innovating with multi-flavored nootropics to cater to diverse tastes and preferences. These cognitive-enhancing supplements are available in various flavors, providing consumers with options that suit their individual tastes. Rollagranola, a UK-based food and beverage company, introduced a Nootropics range with flavors like Calm, Energize, Body and Soul, and Complete Vegan. Each flavor is tailored to specific wellness needs, combining various ingredients to enhance focus, relaxation, physical well-being, and more.
In April 2021, Unilever Global acquired Onnit, a US-based company specializing in nootropics and functional nutrition. This strategic acquisition aligns Onnit with Unilever's expanding portfolio of advanced wellness and supplement brands, positioning the company in the evolving market for health and well-being products.
Major companies operating in the nootropics market include Accelerated Intelligence Inc., AlternaScript Inc. Health Via Modern Nutrition Inc., Mental Mojo LLC., Peak Nootropics, PureLife Bioscience Co. Ltd., Blue Brain Boost Wolfson Holdco Limited Performance Lab Group Ltd., TruBrain, PepsiCo, Superior Supplement Manufacturing, Equinox Nutraceuticals, Natural Stacks Inc., Gaia Herbs Farms., Kimera Koffee LLC., Onnit Labs LLC ., Reckitt Benckiser Group plc., OUTLIERS INC., Teva Pharmaceutical Industries Ltd., United Pharmacies o, Clarity Nootropics, OptiMind, Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, Mylan N.V., UCB S.A., HVMN Inc., BioAdaptives Inc., Powder City
North America was the largest region in the nootropics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nootropics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nootropics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The nootropics market includes revenues earned by entities by modafinil (provigil), adderall, methylphenidate (ritalin), memantine (axura), caffeine, l-theanine, and omega-3 fatty acids. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The main types of drugs categorized as nootropics include prescription nootropics and over-the-counter (OTC) nootropics. Prescription nootropics are often utilized to provide stimulant effects and may be prescribed to counteract symptoms associated with medical conditions such as attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, or narcolepsy. Nootropics are available in various forms, including capsules or tablets, powder, drinks, and others, and are distributed through multiple channels, both online and offline. They find application in memory enhancement, mood and depression treatment, attention and focus improvement, longevity and anti-aging efforts, sleep and recovery promotion, and anxiety treatment.
The nootropics market research report is one of a series of new reports that provides nootropics market statistics, including nootropics industry global market size, regional shares, competitors with a nootropics market share, detailed nootropics market segments, market trends and opportunities, and any further data you may need to thrive in the nootropics industry. This nootropics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nootropics market size has grown rapidly in recent years. It will grow from $4.6 billion in 2023 to $5.29 billion in 2024 at a compound annual growth rate (CAGR) of 15.0%. The growth observed in the historical period can be attributed to several factors, including an aging population, regulatory support for the industry, increased investment in research and development, the expansion of e-commerce, and the rise of esports.
The nootropics market size is expected to see rapid growth in the next few years. It will grow to $9.73 billion in 2028 at a compound annual growth rate (CAGR) of 16.5%.
The anticipated growth in the forecast period can be attributed to various factors, including the increasing stress and cognitive demands in modern lifestyles, globalization, rising disposable incomes allowing for discretionary spending on cognitive enhancement, a growing awareness of mental health, and the expansion of emerging markets. Major trends expected in this forecast period encompass the rise of natural and plant-based nootropics, the emergence of digital nootropics, the use of transcranial stimulation devices, a focus on sustainable and ethical sourcing of nootropic ingredients, and increased collaboration within the industry.
The anticipated growth in the nootropics market is driven by the increasing expenditure on health and wellness. Health and wellness, defined as an individual's method to achieve mental and physical well-being, play a crucial role in the growing demand for nootropics. As the expenditure on healthcare and wellness rises, so does the need for substances like nootropics that contribute to maintaining an individual's health. For example, in September 2021, the Centers for Medicare & Medicaid Services reported a 7.8% increase in prescription drug spending to $378.0 billion, reflecting a faster growth rate compared to the previous year. The escalating expenditure on healthcare and wellness is a key factor propelling the nootropics market.
The nootropics market is poised for growth due to the increasing prevalence of lifestyle diseases. Lifestyle diseases, driven by unhealthy lifestyle choices, lead to cognitive impairment, stress, and reduced energy levels. Nootropics are increasingly used to address these issues, enhancing cognitive function, managing stress, boosting energy, and supporting weight management. The World Health Organization reported 41 million deaths globally in September 2022, with 74% attributed to non-communicable diseases (NCDs). The rising prevalence of lifestyle diseases, such as obesity and diabetes, contributes to the growth of the nootropics market.
The global nootropics market is witnessing the popularity of vegan nootropics, with major companies introducing organic product innovations to meet consumer demands. For instance, BioAdaptives Inc. launched MindMemory, an advanced nootropic designed to enhance memory, mental focus, and concentration, appealing to consumers seeking natural plant and algae-based supplements. This trend reflects the industry's response to the growing demand for vegan-friendly nootropic options.
Major players in the nootropics market are innovating with multi-flavored nootropics to cater to diverse tastes and preferences. These cognitive-enhancing supplements are available in various flavors, providing consumers with options that suit their individual tastes. Rollagranola, a UK-based food and beverage company, introduced a Nootropics range with flavors like Calm, Energize, Body and Soul, and Complete Vegan. Each flavor is tailored to specific wellness needs, combining various ingredients to enhance focus, relaxation, physical well-being, and more.
In April 2021, Unilever Global acquired Onnit, a US-based company specializing in nootropics and functional nutrition. This strategic acquisition aligns Onnit with Unilever's expanding portfolio of advanced wellness and supplement brands, positioning the company in the evolving market for health and well-being products.
Major companies operating in the nootropics market include Accelerated Intelligence Inc., AlternaScript Inc. Health Via Modern Nutrition Inc., Mental Mojo LLC., Peak Nootropics, PureLife Bioscience Co. Ltd., Blue Brain Boost Wolfson Holdco Limited Performance Lab Group Ltd., TruBrain, PepsiCo, Superior Supplement Manufacturing, Equinox Nutraceuticals, Natural Stacks Inc., Gaia Herbs Farms., Kimera Koffee LLC., Onnit Labs LLC ., Reckitt Benckiser Group plc., OUTLIERS INC., Teva Pharmaceutical Industries Ltd., United Pharmacies o, Clarity Nootropics, OptiMind, Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, Mylan N.V., UCB S.A., HVMN Inc., BioAdaptives Inc., Powder City
North America was the largest region in the nootropics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nootropics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nootropics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The nootropics market includes revenues earned by entities by modafinil (provigil), adderall, methylphenidate (ritalin), memantine (axura), caffeine, l-theanine, and omega-3 fatty acids. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Nootropics Market Characteristics3. Nootropics Market Trends And Strategies31. Global Nootropics Market Competitive Benchmarking32. Global Nootropics Market Competitive Dashboard33. Key Mergers And Acquisitions In The Nootropics Market
4. Nootropics Market - Macro Economic Scenario
5. Global Nootropics Market Size and Growth
6. Nootropics Market Segmentation
7. Nootropics Market Regional And Country Analysis
8. Asia-Pacific Nootropics Market
9. China Nootropics Market
10. India Nootropics Market
11. Japan Nootropics Market
12. Australia Nootropics Market
13. Indonesia Nootropics Market
14. South Korea Nootropics Market
15. Western Europe Nootropics Market
16. UK Nootropics Market
17. Germany Nootropics Market
18. France Nootropics Market
19. Italy Nootropics Market
20. Spain Nootropics Market
21. Eastern Europe Nootropics Market
22. Russia Nootropics Market
23. North America Nootropics Market
24. USA Nootropics Market
25. Canada Nootropics Market
26. South America Nootropics Market
27. Brazil Nootropics Market
28. Middle East Nootropics Market
29. Africa Nootropics Market
30. Nootropics Market Competitive Landscape And Company Profiles
34. Nootropics Market Future Outlook and Potential Analysis
35. Appendix
Executive Summary
Nootropics Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on nootropics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- All data from the report will also be delivered in an excel dashboard format.
Description:
Where is the largest and fastest growing market for nootropics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
- Markets Covered: 1) By Drug Type: Prescription Nootropics; OTC Nootropics 2) By Form: Capsules or Tablets; Powder; Drinks; Other Forms 3) By Distribution Channel: Offline; Online 4) By Application: Memory Enhancement; Mood and Depression; Attention and Focus; Longevity and Anti-aging; Sleep and Recovery; Anxiety
- Companies Mentioned: Accelerated Intelligence Inc.; AlternaScript Inc. Health Via Modern Nutrition Inc.; Mental Mojo LLC.; Peak Nootropics; PureLife Bioscience Co. Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accelerated Intelligence Inc.
- AlternaScript Inc.
- Health Via Modern Nutrition Inc.
- Mental Mojo LLC.
- Peak Nootropics
- PureLife Bioscience Co. Ltd.
- Blue Brain Boost Wolfson Holdco Limited Performance Lab Group Ltd.
- TruBrain
- PepsiCo
- Superior Supplement Manufacturing
- Equinox Nutraceuticals
- Natural Stacks Inc.
- Gaia Herbs Farms.
- Kimera Koffee LLC.
- Onnit Labs LLC .
- Reckitt Benckiser Group plc.
- OUTLIERS INC.
- Teva Pharmaceutical Industries Ltd.
- United Pharmacies o
- Clarity Nootropics
- OptiMind
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Mylan N.V.
- UCB S.A.
- HVMN Inc.
- BioAdaptives Inc.
- Powder City
Methodology
LOADING...